Using accounting‐based and loan‐related information to estimate the cure probability of a defaulted company

Published date01 September 2021
AuthorChristian Lohmann,Thorsten Ohliger
Date01 September 2021
DOIhttp://doi.org/10.1111/eufm.12279
Eur Financ Manag. 2021;27:620–640.620
|
wileyonlinelibrary.com/journal/eufm
DOI: 10.1111/eufm.12279
ORIGINAL ARTICLE
Using accounting‐based and loan‐related
information to estimate the cure probability of
a defaulted company
Christian Lohmann
1,2
|Thorsten Ohliger
3
1
Schumpeter School of Business and
Economics, University of Wuppertal,
Germany
2
Faculty for Social Sciences, Economics,
and Business Administration, University of
Bamberg, Germany
3
parcIT GmbH, Cologne, Germany
Correspondence
Christian Lohmann, Schumpeter School of
Business and Economics, University of
Wuppertal, Gaußstraße 20, 42119
Wuppertal, Germany.
Email: lohmann@wiwi.uni-wuppertal.de
Abstract
The cure of a defaulted company has important
implications for the estimation of the loss given
default. In this study, we estimate the probability of a
defaulted company being cured using data on a large
international sample of defaulted companies. More
specifically, we examine whether historic accounting
information on a defaulted company and loan‐related
information are associated with that company's
probability of being cured. The main finding of our
analysis is that both accounting‐based and loan‐
related independent variables increase the validity of
cure prediction models.
KEYWORDS
accounting information, company cure, collateralization, cure
probability, defaulted company, Global Credit Data
JEL CLASSIFICATION
C53; D81; G24; G33
EUROPEAN
FINANCIAL MANAGEMENT
----------------------------------------------------------------------------------------------------
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
© 2020 The Authors. European Financial Management published by John Wiley & Sons Ltd.
We thank the editor (John A. Doukas) for his encouragement and his comments that led to improvements to the paper.
We also thank two anonymous referees for their constructive feedback and suggestions, all of which have proved most
helpful. Furthermore, we thank Global Credit Data for providing the data applied and we are grateful for technical
support from Nunzia Rainone and Christophe Van Goey.
1|INTRODUCTION
The loss given default (LGD) values of companies that default and are subsequently cured tend
to be low. As cured companies resume repaying both their loan and the interest on that loan,
the LGD values they exhibit are frequently equal to or close to 0. This indicates that a defaulted
company's probability of being cured greatly affects the LGD. Consequently, accurately esti-
mating a company's probability of being cured could help improve estimations of the LGD.
The LGD distribution usually exhibits a bimodal structure that reaches the maximum number of
observations when LGD values are close to 0 and when they are close to 1. The value of the LGD is
close to 0 if either a defaulted company is cured or the collaterals and securities sufficiently cover the
amount outstanding. Estimating a defaulted company's probability of being cured would therefore
allow us to estimate the LGD values more accurately, considering that cure is associated with specific
low LGD values. Estimating the LGD on the basis of historic data commonly involves taking into
account observations of cured companies with LGD = 0 (Calabrese & Zenga, 2010;Renault&
Scaillet, 2004). However, incorporating the potential cure event of a defaulted company into the LGD
estimation requires a valid estimation of the probability that a defaulted company will be cured.
In the literature, there is no consensus as to whether a company's probability of being cured is
associated with the estimation of LGD or with the estimation of the probability of default (PD). The
case where the cure probability has to be taken into account by estimating LGD is in line with the
regulatory specification that the cure event does not affect the assessment of the previous default
event. For example, the Capital Requirement Regulation (CRR) of the European Union provides a
rigorous definition of the default event in article 178 CRR (European Banking Authority, 2016),
which, however, does not distinguish between soft and hard defaults. In the second case, the
probability of a company being cured is taken into account when estimating the PD. This esti-
mation requires both a default model that takes into account all defaulted companies, irrespective of
whether they are subsequently cured, and a cure model to estimate a defaulted company's prob-
ability of being cured. Such estimations may involve a mixture cure model; that is, a special type of
survival model that incorporates the possibility of cure (Beran & Djaidja, 2007; Dirick, Claeskens, &
Baesens, 2015,2017;Mo&Yau,2010; Tong, Mues, & Thomas, 2012; Yildirim, 2008; Zhang, Yang,
Kelleher, & Si, 2019). Alternatively, they may involve a cure‐after‐default model, which combines
an upstream cure model with a subsequent default model (Wolter & Rösch, 2014).
Rigorous definitions of default allow us to estimate additionally a defaulted company's
probability of being cured (PC), which improves estimations of the LGD. When the PC is
accurately estimated, it is possible to separate the LGD into two distinct components. The first
component relates to the expected LGD in the case of defaulted companies that are not sub-
sequently cured. This component can be calculated by multiplying the downside probability
(1 –PC) and the LGD given a company's non‐cure (LGD
NonCure
). The second component
represents the expected LGD in the case of defaulted companies that are subsequently cured;
this component can be calculated by multiplying the upside probability PC and the LGD given a
company's cure (LGD
Cure
). Thus the LGD consists of two components:
LGD = (1 −PC) LGD + PC LGD
.
NonCure Cure
⋅⋅ (1)
Breaking down the estimation of the LGD into LGD
NonCure
and LGD
Cure
reduces the bi-
modal nature of the LGD distribution, because cured companies largely explain why the LGD is
often 0, although there are no sufficient collaterals or securities, if any. The LGD
Cure
component
often takes a value close to 0 and also exhibits very low scatter. In comparison, LGD
NonCure
LOHMANN AND OHLIGER EUROPEAN
FINANCIAL MANAGEMENT
|
621

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex